MedPath

Impact of hydroxychloroquine dosage on visual function in individuals with rheumatoid arthritis

Not Applicable
Conditions
Health Condition 1: H538- Other visual disturbances
Registration Number
CTRI/2024/07/071173
Lead Sponsor
Thondavada Lalitha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age group >18 years old

2.Both males and females

3.Individuals diagnosed with rheumatoid arthritis under hydroxychloroquine dosage

Exclusion Criteria

1.Any systemic disease other than rheumatoid arthritis

2.History of contact lens usage & computer use of more than 6 hours

3.Patients with a history of ocular injury or intra-ocular surgery

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual acuity, <br/ ><br>contrast sensitivity, <br/ ><br>color vision, <br/ ><br>stereo acuity, <br/ ><br>photo stress testTimepoint: One time measurement
Secondary Outcome Measures
NameTimeMethod
Tear film quality , Intraocular pressure and <br/ ><br>Structural changesTimepoint: One time measurement
© Copyright 2025. All Rights Reserved by MedPath